» Articles » PMID: 6662158

Physical Exercise and Digoxin Binding to Skeletal Muscle: Relation to Exercise Intensity

Overview
Specialty Pharmacology
Date 1983 Jan 1
PMID 6662158
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of a 1 h bicycle exercise test on digoxin concentration in skeletal muscle (thigh) and serum was studied in 10 healthy men, who had ingested digoxin 0.5 mg daily for 2 weeks. During maintenance digoxin treatment each subject performed 2 exercise tests, at 70-90 W and 140-180 W both 24 h after the last dose, at a 2-7 day interval. During exercise at the lower work load the mean skeletal muscle digoxin concentration increased by 9% (n.s.) and the mean serum digoxin concentration decreased by 26% (p less than 0.001). The high work load induced a mean increase in skeletal muscle digoxin of 20% (p less than 0.05) and a mean decrease in serum digoxin of 40% (p less than 0.001). The results indicate that the increased uptake of digoxin into exercised skeletal muscle and the decrease in serum digoxin during exercise is related to the intensity of the exercise.

Citing Articles

Oral digoxin effects on exercise performance, K regulation and skeletal muscle Na ,K -ATPase in healthy humans.

Sostaric S, Petersen A, Goodman C, Gong X, Aw T, Brown M J Physiol. 2022; 600(16):3749-3774.

PMID: 35837833 PMC: 9541254. DOI: 10.1113/JP283017.


The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

Fagiolino P, Eiraldi R, Vazquez M Clin Pharmacokinet. 2006; 45(5):433-48.

PMID: 16640451 DOI: 10.2165/00003088-200645050-00001.


Physical exercise and binding of digoxin to skeletal muscle--effect of muscle activation frequency.

Joreteg T, Jogestrand T Eur J Clin Pharmacol. 1984; 27(5):567-70.

PMID: 6519161 DOI: 10.1007/BF00556893.


Oral salbutamol decreases serum digoxin concentration.

Edner M, Jogestrand T Eur J Clin Pharmacol. 1990; 38(2):195-7.

PMID: 2338119 DOI: 10.1007/BF00265984.


Influence of exercise on the pharmacokinetics of drugs.

van Baak M Clin Pharmacokinet. 1990; 19(1):32-43.

PMID: 2199126 DOI: 10.2165/00003088-199019010-00003.


References
1.
Marsh A, Lloyd B, Taylor R . The influence of heart rate on digoxin-induced inhibition of myocardial Na+-K+-ATPase activity in the dog. Clin Exp Pharmacol Physiol. 1981; 8(3):283-6. DOI: 10.1111/j.1440-1681.1981.tb00161.x. View

2.
Jogestrand T, Nordlander R . Serum digoxin determination in outpatients--need for standardization. Br J Clin Pharmacol. 1983; 15(1):55-8. PMC: 1427817. DOI: 10.1111/j.1365-2125.1983.tb01463.x. View

3.
Jogestrand T . Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm. Eur J Clin Pharmacol. 1980; 17(4):243-50. DOI: 10.1007/BF00625797. View

4.
Smith T, Butler Jr V, Haber E . Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med. 1969; 281(22):1212-6. DOI: 10.1056/NEJM196911272812203. View

5.
Francis D, Georoff M, Jackson B, MARCUS F . The effect of insulin and glucose on the myocardial and skeletal muscle uptake of tritiated digoxin in acutely hypokalemic and normokalemic dogs. J Pharmacol Exp Ther. 1974; 188(3):564-74. View